By integrating bioinformatics analysis, gene expression levels and survival analysis, we identified five differentially co-expressed hub genes associated with estrogen receptor signaling associated with DLBCL pathogenesis. The gene discussed is ESR1; the disease is diffuse large B-cell lymphoma.